Morgan Stanley China A Share Fund Inc (CAF) 18.33

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Morgan Stanley China A Share Fund Inc (CAF) 18.33 $CAF

Look for Shares of Morgan Stanley China A Share Fund to Potentially Pullback after Yesterday's 2.68% Rise
Comtex SmarTrend(R) - Mon Mar 21, 5:04PM CDT
Morgan Stanley China A Share Fund (NYSE:CAF) traded in a range yesterday that spanned from a low of $17.04 to a high of $17.50. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $16.95 on volume of 215,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund Shares Down 23.3% Since SmarTrend's Sell Call (CAF)
Comtex SmarTrend(R) - Thu Feb 04, 12:58PM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 1 month, Morgan Stanley China A Share Fund has returned 23.32% as of today's recent price of $15.65.
CAF: 18.33 (+0.08)

Downtrend Call Working As Morgan Stanley China A Share Fund Stock Falls 24.7% (CAF)
Comtex SmarTrend(R) - Thu Jan 28, 10:40AM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 1 month, Morgan Stanley China A Share Fund has returned 24.69% as of today's recent price of $15.37.
CAF: 18.33 (+0.08)

Shares of CAF Down 22.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 21, 9:40AM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 3 weeks, Morgan Stanley China A Share Fund has returned 22.15% as of today's recent price of $15.89.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund Down 18.2% Since SmarTrend Downtrend Call (CAF)
Comtex SmarTrend(R) - Wed Jan 13, 10:19AM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 2 weeks, Morgan Stanley China A Share Fund has returned 18.18% as of today's recent price of $16.70.
CAF: 18.33 (+0.08)

-18.9% Return Seen to Date on SmarTrend Morgan Stanley China A Share Fund Call (CAF)
Comtex SmarTrend(R) - Tue Dec 29, 10:47AM CST
SmarTrend identified an Uptrend for Morgan Stanley China A Share Fund (NYSE:CAF) on October 20th, 2015 at $25.26. In approximately 2 months, Morgan Stanley China A Share Fund has returned 18.87% as of today's recent price of $20.49.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund, Inc. Declares a Dividend
BusinessWire - Tue Dec 08, 3:30PM CST
The Morgan Stanley China A Share Fund, Inc. (the "Fund" today declared the following dividend.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund, Inc. Announces Ability to Invest Through Stock Connect
BusinessWire - Fri Nov 13, 3:30PM CST
Morgan Stanley China A Share Fund, Inc. (NYSE:CAF) (the "Fund" announced today that it may invest in China A-shares through the Shanghai-Hong Kong Stock Connect Program ("Stock Connect".
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund Has Returned 25.4% Since SmarTrend Recommendation (CAF)
Comtex SmarTrend(R) - Mon Oct 19, 9:32AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 4 months, Morgan Stanley China A Share Fund has returned 25.37% as of today's recent price of $25.08.
CAF: 18.33 (+0.08)

28.8% Return Seen to Date on SmarTrend Morgan Stanley China A Share Fund Call (CAF)
Comtex SmarTrend(R) - Fri Oct 09, 5:30PM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 4 months, Morgan Stanley China A Share Fund has returned 28.82% as of today's recent price of $23.92.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund Down 30.8% Since SmarTrend Downtrend Call (CAF)
Comtex SmarTrend(R) - Fri Oct 02, 4:58PM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 4 months, Morgan Stanley China A Share Fund has returned 30.75% as of today's recent price of $23.27.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund Down 27.1% Since SmarTrend Downtrend Call (CAF)
Comtex SmarTrend(R) - Fri Sep 11, 9:53AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 3 months, Morgan Stanley China A Share Fund has returned 27.09% as of today's recent price of $24.50.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund Shares Down 11.9% Since SmarTrend's Sell Call (CAF)
Comtex SmarTrend(R) - Thu Aug 13, 10:25AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 2 months, Morgan Stanley China A Share Fund has returned 11.92% as of today's recent price of $29.60.
CAF: 18.33 (+0.08)

Morgan Stanley China A Share Fund Has Returned 16.3% Since SmarTrend Recommendation (CAF)
Comtex SmarTrend(R) - Tue Jul 28, 9:43AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 1 month, Morgan Stanley China A Share Fund has returned 16.32% as of today's recent price of $28.12.
CAF: 18.33 (+0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 398

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

GE HealthCare Launches Innovative Ultrasound Systems for Women

Updated Category News Views 289

GE HealthCare Unveils New Voluson Expert Series Ultrasound Systems GE HealthCare recently announced the launch of its enhanced Voluson Expert Series ultrasound systems, aiming to improve early detection and streamline exam efficiency in women's healthcare. With FDA 510(k) clearance achieved, these innovative systems—Voluson Expert 22, 20, and 18—combine...

Continue Reading
Newmont Corp: Dominating Gold Mining with Impressive Gains

Updated Category News Views 291

Newmont Corp's Standout Performance In a market filled with technology giants, Newmont Corp (NYSE: NEM) is making headlines for its remarkable performance this year. Rising an astonishing 106% year-to-date (YTD), the largest gold miner is turning ore into a sought-after treasure for investors. The stability of gold prices amid ongoing inflation concerns has positioned...

Continue Reading
Seeking Justice: Class Action Lawsuit for Fiserv, Inc. Investors

Updated Category News Views 221

Overview of the Fiserv, Inc. Class Action Investors who have experienced significant losses in Fiserv, Inc. (NYSE: FI) stock are encouraged to take action. Robbins LLP is currently leading a class action lawsuit, aimed at helping those impacted during a specific class period of the company’s troubling financial disclosures. Why Join the Class Action? This initiative is...

Continue Reading
Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 262

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
Probe Gold's Annual Meeting Highlights Key Voting Outcomes

Updated Category News Views 181

Key Highlights from Probe Gold's Annual General Meeting Probe Gold Inc., with its stock traded as TSX: PRB and OTCQB: PROBF, held its Annual General Meeting (AGM) where significant decisions were made that will shape the company's future. This meeting was filled with exciting developments as shareholders came together to participate in the governance of the company....

Continue Reading